Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation

Kristin Schwerbel, Anne Kamitz, Natalie Krahmer, Nicole Hallahan, Markus Jähnert, Pascal Gottmann, Sandra Lebek, Tanja Schallschmidt, Danny Arends, Fabian Schumacher, Burkhard Kleuser, Tom Haltenhof, Florian Heyd, Sofiya Gancheva, Karl W. Broman, Michael Roden, Hans Georg Joost, Alexandra Chadt, Hadi Al-Hasani, Heike VogelWenke Jonas*, Annette Schürmann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)
3 Downloads (Pure)


Background & Aims: Currently, only a few genetic variants explain the heritability of fatty liver disease. Quantitative trait loci (QTL) analysis of mouse strains has identified the susceptibility locus Ltg/NZO (liver triglycerides from New Zealand obese [NZO] alleles) on chromosome 18 as associating with increased hepatic triglycerides. Herein, we aimed to identify genomic variants responsible for this association. Methods: Recombinant congenic mice carrying 5.3 Mbp of Ltg/NZO were fed a high-fat diet and characterized for liver fat. Bioinformatic analysis, mRNA profiles and electrophoretic mobility shift assays were performed to identify genes responsible for the Ltg/NZO phenotype. Candidate genes were manipulated in vivo by injecting specific microRNAs into C57BL/6 mice. Pulldown coupled with mass spectrometry-based proteomics and immunoprecipitation were performed to identify interaction partners of IFGGA2. Results: Through positional cloning, we identified 2 immunity-related GTPases (Ifgga2, Ifgga4) that prevent hepatic lipid storage. Expression of both murine genes and the human orthologue IRGM was significantly lower in fatty livers. Accordingly, liver-specific suppression of either Ifgga2 or Ifgga4 led to a 3–4-fold greater increase in hepatic fat content. In the liver of low-fat diet-fed mice, IFGGA2 localized to endosomes/lysosomes, while on a high-fat diet it associated with lipid droplets. Pulldown experiments and proteomics identified the lipase ATGL as a binding partner of IFGGA2 which was confirmed by co-immunoprecipitation. Both proteins partially co-localized with the autophagic marker LC3B. Ifgga2 suppression in hepatocytes reduced the amount of LC3B-II, whereas overexpression of Ifgga2 increased the association of LC3B with lipid droplets and decreased triglyceride storage. Conclusion: IFGGA2 interacts with ATGL and protects against hepatic steatosis, most likely by enhancing the binding of LC3B to lipid droplets. Lay summary: The genetic basis of non-alcoholic fatty liver disease remains incompletely defined. Herein, we identified members of the immunity-related GTPase family in mice and humans that act as regulators of hepatic fat accumulation, with links to autophagy. Overexpression of the gene Ifgga2 was shown to reduce hepatic lipid storage and could be a therapeutic target for the treatment of fatty liver disease.

Original languageEnglish
Pages (from-to)771-782
Number of pages12
JournalJournal of Hepatology
Issue number4
Early online date4 May 2020
Publication statusPublished - 1 Oct 2020
Externally publishedYes


Dive into the research topics of 'Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation'. Together they form a unique fingerprint.

Cite this